A keynote review. Towards rational psychotropic prescribing for people with learning disability.
The use of psychotropic medication to treat emotional and behavioural disorders among people with learning disability has been a cause of concern for some time. It has also been the subject of numerous surveys and reviews in a number of countries. The types and uses of psychotropic drugs, and some o...
| Published in: | British Journal of Learning Disabilities Vol. 25; no. 2; pp. 46 - 53 |
|---|---|
| Main Author: | |
| Format: | review Journal Article |
| Published: |
Wiley-Blackwell
Jun1997
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107247973&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 107247973 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13544187 F04 jtl: British Journal of Learning Disabilities issn: 13544187 maglogo: Y pubinfo: dt: Jun1997 vid: 25 iid: 2 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 107247973 107247973 1998014136 107247973 ppf: 46 ppct: 7 formats: tig: atl: A keynote review. Towards rational psychotropic prescribing for people with learning disability. aug: au: Clarke DJ affil: Queen Elizabeth Psychiatric Hospital, Birmingham, UK sug: subj: Mental Disorders Drug Therapy Psychotropic Drugs Administration and Dosage Developmental Disabilities Schizophrenia Depression Antidepressive Agents Child Behavior Disorders Cognition Inpatients Outpatients ab: The use of psychotropic medication to treat emotional and behavioural disorders among people with learning disability has been a cause of concern for some time. It has also been the subject of numerous surveys and reviews in a number of countries. The types and uses of psychotropic drugs, and some of the research evidence regarding the prescribing of these compounds to people with learning disability, are reviewed. Good practice is based on maximising the benefits and minimising the risks of prescribing. Criticisms of 'inappropriate' prescribing have often been based on assumptions that may not apply in clinical practice, especially when other treatment options have been exhausted. However, few clinicians would dispute the need for better evidence about the efficacy of drugs in the management of behaviours that challenge services. Advances in neurochemistry and psychopharmacology have opened up the possibility of more rational approaches to the treatment of maladaptive behaviours associated with learning disability, based on a knowledge of underlying biological abnormalities and the actions of drugs on specific receptors or neuroregulatory systems. Clinical trials with sound methodology are beginning to appear, but there are many unanswered questions. pubtype: Academic Journal doctype: review Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|